BEUDAMED
    1,170 results · 20ms · Sources: EU EUDAMED, US FDA
    Filters Classification: FDA Class 3 ×

    Cancer-Related Germline Gene Mutation Detection System

    FDA Pre-Market Approval
    FDA Class 3 ·MyChoice® CDx

    Neuromodulator For Obesity

    FDA Pre-Market Approval
    FDA Class 3 ·MAESTRO RECHARGEABLE SYSTEM

    Neuromodulator For Obesity

    FDA Pre-Market Approval
    FDA Class 3 ·MAESTRO RECHARGEABLE SYSTEM

    Cancer-Related Germline Gene Mutation Detection System

    FDA Pre-Market Approval
    FDA Class 3 ·BRACAnalysis CDx®

    Cancer-Related Germline Gene Mutation Detection System

    FDA Pre-Market Approval
    FDA Class 3 ·BRACAnalysis CDx

    Cancer-Related Germline Gene Mutation Detection System

    FDA Pre-Market Approval
    FDA Class 3 ·BRACAnalysis CDx

    Cancer-Related Germline Gene Mutation Detection System

    FDA Pre-Market Approval
    FDA Class 3 ·BRACAnalysis CDx

    Combination Compression/Decompression Manual Chest Pump With Impedance Respiratory Valve

    FDA Pre-Market Approval
    FDA Class 3 ·RESQCPR SYSTEM

    Combination Compression/Decompression Manual Chest Pump With Impedance Respiratory Valve

    FDA Pre-Market Approval
    FDA Class 3 ·ResQCPR System

    Neuromodulator For Obesity

    FDA Pre-Market Approval
    FDA Class 3 ·MAESTRO RECHARGEABLE SYSTEM

    Cancer-Related Germline Gene Mutation Detection System

    FDA Pre-Market Approval
    FDA Class 3 ·MyChoice CDx®

    Neuromodulator For Obesity

    FDA Pre-Market Approval
    FDA Class 3 ·MAESTRO RECHARGEABLE SYSTEM

    Cancer-Related Germline Gene Mutation Detection System

    FDA Pre-Market Approval
    FDA Class 3 ·BRACAnalysis CDx®

    Neuromodulator For Obesity

    FDA Pre-Market Approval
    FDA Class 3 ·MAESTRO RECHARGEABLE SYSTEM

    Neuromodulator For Obesity

    FDA Pre-Market Approval
    FDA Class 3 ·MAESTRO RECHARGEABLE SYSTEM

    Neuromodulator For Obesity

    FDA Pre-Market Approval
    FDA Class 3 ·Maestro Rechargeable System

    Cancer-Related Germline Gene Mutation Detection System

    FDA Pre-Market Approval
    FDA Class 3 ·BRACAnalysis CDx

    Neuromodulator For Obesity

    FDA Pre-Market Approval
    FDA Class 3 ·Maestro Rechargeable System

    Neuromodulator For Obesity

    FDA Pre-Market Approval
    FDA Class 3 ·MAESTRO RECHARGEABLE SYSTEM

    Cancer-Related Germline Gene Mutation Detection System

    FDA Pre-Market Approval
    FDA Class 3 ·BRACAnalysis CDx®